Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 728673, 10 pages
http://dx.doi.org/10.1155/2014/728673
Review Article

The Roles of CD147 and/or Cyclophilin A in Kidney Diseases

1Department of Critical Care Medicine, Shandong Provincial Hospital, Shandong University, 324 Jingwu Road, Jinan 250021, China
2Department of Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, 6 Tiantan Xili, Beijing 100050, China

Received 2 July 2014; Revised 30 October 2014; Accepted 26 November 2014; Published 17 December 2014

Academic Editor: Dennis D. Taub

Copyright © 2014 Xin Qu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Muramatsu, “Basigin: a multifunctional membrane protein with an emerging role in infections by malaria parasites,” Expert Opinion on Therapeutic Targets, vol. 16, no. 10, pp. 999–1001, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Kato, Y. Yuzawa, T. Kosugi et al., “The E-selectin ligand basigin/CD147 is responsible for neutrophil recruitment in renal ischemia/reperfusion,” Journal of the American Society of Nephrology, vol. 20, no. 7, pp. 1565–1576, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. V. Yurchenko, S. Constant, E. Eisenmesser, and M. Bukrinsky, “Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics,” Clinical & Experimental Immunology, vol. 160, no. 3, pp. 305–317, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Nigro, G. Pompilio, and M. C. Capogrossi, “Cyclophilin A: a key player for human disease,” Cell Death and Disease, vol. 4, no. 10, article e888, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. U. H. Weidle, W. Scheuer, D. Eggle, S. Klostermann, and H. Stockinger, “Cancer-related issues of CD147,” Cancer Genomics and Proteomics, vol. 7, no. 3, pp. 157–169, 2010. View at Google Scholar · View at Scopus
  6. H. Seulberger, C. M. Unger, and W. Risau, “HT7, Neurothelin, Basigin, gp42 and OX-47—Many names for one developmentally regulated immuno-globulin-like surface glycoprotein on blood-brain barrier endothelium, epithelial tissue barriers and neurons,” Neuroscience Letters, vol. 140, no. 1, pp. 93–97, 1992. View at Publisher · View at Google Scholar · View at Scopus
  7. V. L. Schuster, R. Lu, N. Kanai et al., “Cloning of the rabbit homologue of mouse “basigin” and rat “OX-47”: kidney cell type-specific expression, and regulation in collecting duct cells,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1311, no. 1, pp. 13–19, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Shimada, H. Yamabe, H. Osawa et al., “Extracellular matrix metalloproteinase inducer is expressed in the proximal tubular epithelial cells of the human kidney,” Nephrology, vol. 14, no. 2, pp. 171–178, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. R. E. Handschumacher, M. W. Harding, J. Rice, R. J. Drugge, and D. W. Speicher, “Cyclophilin: a specific cytosolic binding protein for cyclosporin A,” Science, vol. 226, no. 4674, pp. 544–547, 1984. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Obchoei, S. Wongkhan, C. Wongkham, M. Li, Q. Yao, and C. Chen, “Cyclophilin a: Potential functions and therapeutic target for human cancer,” Medical Science Monitor, vol. 15, no. 11, pp. RA221–RA232, 2009. View at Google Scholar · View at Scopus
  11. P. Seizer, M. Gawaz, and A. E. May, “Cyclophilin A and EMMPRIN (CD147) in cardiovascular diseases,” Cardiovascular Research, vol. 102, no. 1, pp. 17–23, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Willenbrink, J. Halaschek, S. Schuffenhauer, J. Kunz, and A. Steinkasserer, “Cyclophilin A, the major intracellular receptor for the immunosuppressant cyclosporin A, maps to chromosome 7p11.2-p13: four pseudogenes map to chromosomes 3, 10, 14, and 18,” Genomics, vol. 28, no. 1, pp. 101–104, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Song, X. Zhang, X.-B. Ren et al., “Cyclophilin A (CyPA) induces chemotaxis independent of its peptidylprolyl cis-trans isomerase activity: direct binding between CyPA and the ectodomain of CD147,” Journal of Biological Chemistry, vol. 286, no. 10, pp. 8197–8203, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Suzuki, Z.-G. Jin, D. F. Meoli, T. Matoba, and B. C. Berk, “Cyclophilin A is secreted by a vesicular pathway in vascular smooth muscle cells,” Circulation Research, vol. 98, no. 6, pp. 811–817, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. G. Jin, M. G. Melaragno, D.-F. Liao et al., “Cyclophilin A is a secreted growth factor induced by oxidative stress,” Circulation Research, vol. 87, no. 9, pp. 789–796, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. J. W. Dear, K. J. Simpson, M. P. J. Nicolai et al., “Cyclophilin A is a damage-associated molecular pattern molecule that mediates acetaminophen-induced liver injury,” The Journal of Immunology, vol. 187, no. 6, pp. 3347–3352, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. N. N. Soe, M. Sowden, P. Baskaran et al., “Acetylation of cyclophilin A is required for its secretion and vascular cell activation,” Cardiovascular Research, vol. 101, no. 3, pp. 444–453, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Sherry, N. Yarlett, A. Strupp, and A. Cerami, “Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 8, pp. 3511–3515, 1992. View at Publisher · View at Google Scholar · View at Scopus
  19. Q. Xu, M. C. Leiva, S. A. Fischkoff, R. E. Handschumacher, and C. R. Lyttle, “Leukocyte chemotactic activity of cyclophilin,” The Journal of Biological Chemistry, vol. 267, no. 17, pp. 11968–11971, 1992. View at Google Scholar · View at Scopus
  20. F. Allain, C. Vanpouille, M. Carpentier, M.-C. Slomianny, S. Durieux, and G. Spik, “Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 5, pp. 2714–2719, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. V. Yurchenko, G. Zybarth, M. O'Connor et al., “Active site residues of cyclophilin A are crucial for its signaling activity via CD147,” Journal of Biological Chemistry, vol. 277, no. 25, pp. 22959–22965, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Lang, F. X. Schmid, and G. Fischer, “Catalysis of protein folding by prolyl isomerase,” Nature, vol. 329, no. 6136, pp. 268–270, 1987. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Solstad, S. J. Bains, J. Landskron et al., “CD147 (Basigin/Emmprin) identifies FoxP3+CD45RO+CTLA4+-activated human regulatory T cells,” Blood, vol. 118, no. 19, pp. 5141–5151, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Satoh, H. Shimokawa, and B. C. Berk, “Cyclophilin A: promising new target in cardiovascular therapy,” Circulation Journal, vol. 74, no. 11, pp. 2249–2256, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. I. Tegeder, A. Schumacher, S. John et al., “Elevated serum cyclophilin levels in patients with severe sepsis,” Journal of Clinical Immunology, vol. 17, no. 5, pp. 380–386, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. E. J. Stemmy, A. S. Benton, J. Lerner, S. Alcala, S. L. Constant, and R. J. Freishtat, “Extracellular cyclophilin levels associate with parameters of asthma in phenotypic clusters,” The Journal of Asthma, vol. 48, no. 10, pp. 986–993, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. C.-S. Chang, S.-L. Su, C.-C. Chang et al., “Cyclophilin-A: a novel biomarker for untreated male essential hypertension,” Biomarkers, vol. 18, no. 8, pp. 716–720, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Peng, S. Vijayakumar, C. Schiene-Fischer et al., “Secreted cyclophilin A, a peptidylprolyl cis-trans isomerase, mediates matrix assembly of Hensin, a protein implicated in epithelial differentiation,” The Journal of Biological Chemistry, vol. 284, no. 10, pp. 6465–6475, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. W. Yuan, H. Ge, and B. He, “Pro-inflammatory activities induced by CyPA-EMMPRIN interaction in monocytes,” Atherosclerosis, vol. 213, no. 2, pp. 415–421, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Wei, Y. Jinchuan, L. Yi, W. Jun, W. Zhongqun, and W. Cuiping, “Antiapoptotic and proapoptotic signaling of cyclophilin A in endothelial cells,” Inflammation, vol. 36, no. 3, pp. 567–572, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Boulos, B. P. Meloni, P. G. Arthur, B. Majda, C. Bojarski, and N. W. Knuckey, “Evidence that intracellular cyclophilin A and cyclophilin A/CD147 receptor-mediated ERK1/2 signalling can protect neurons against in vitro oxidative and ischemic injury,” Neurobiology of Disease, vol. 25, no. 1, pp. 54–64, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Nakamura, J. Kodama, A. Hongo, and Y. Hiramatsu, “Role of emmprin in endometrial cancer,” BMC Cancer, vol. 12, article 191, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. G. D. Grass, L. Dai, Z. Qin, C. Parsons, and B. P. Toole, “CD147: regulator of hyaluronan signaling in invasiveness and chemoresistance,” in Advances in Cancer Research, vol. 123, pp. 351–373, 2014. View at Google Scholar
  34. S. Fossum, S. Mallett, and A. N. Barclay, “The MRC OX-47 antigen is a member of the immunoglobulin superfamily with an unusual transmembrane sequence,” European Journal of Immunology, vol. 21, no. 3, pp. 671–679, 1991. View at Publisher · View at Google Scholar · View at Scopus
  35. R. DeCastro, Y. Zhang, H. Guo et al., “Human keratinocytes express EMMPRIN, an extracellular matrix metalloproteinase inducer,” Journal of Investigative Dermatology, vol. 106, no. 6, pp. 1260–1265, 1996. View at Publisher · View at Google Scholar · View at Scopus
  36. C. L. Nehme, B. E. Fayos, and J. R. Bartles, “Distribution of the integral plasma membrane glycoprotein CE9 (MRC OX-47) among rat tissues and its induction by diverse stimuli of metabolic activation,” Biochemical Journal, vol. 310, part 2, pp. 693–698, 1995. View at Google Scholar · View at Scopus
  37. S. M. Agrawal, C. Silva, J. Wang, J. P. Tong, and V. W. Yong, “A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis,” Journal of Neuroinflammation, vol. 9, article 64, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Muramatsu and T. Miyauchi, “Basigin (CD147): a multifunctional transmembrane protien involved in reproduction, neural function, inflammation and tumor invasion,” Histology and Histopathology, vol. 18, no. 3, pp. 981–987, 2003. View at Google Scholar · View at Scopus
  39. J. M. Fadool and P. J. Linser, “5A11 antigen is a cell recognition molecule which is involved in neuronal-glial interactions in avian neural retina,” Developmental Dynamics, vol. 196, no. 4, pp. 252–262, 1993. View at Publisher · View at Google Scholar · View at Scopus
  40. C. L. Nehme, M. M. Cesario, D. G. Myles, D. E. Koppel, and J. R. Bartles, “Breaching the diffusion barrier that compartmentalizes the transmembrane glycoprotein CE9 to the posterior-tail plasma membrane domain of the rat spermatozoon,” The Journal of Cell Biology, vol. 120, no. 3, pp. 687–694, 1993. View at Publisher · View at Google Scholar · View at Scopus
  41. F. Altruda, P. Cervella, M. Lou Gaeta et al., “Cloning of cDNA for a novel mouse membrane glycoprotein (gp42): shared identity to histocompatibility antigens, immunoglobulins and neural-cell adhesion molecules,” Gene, vol. 85, no. 2, pp. 445–451, 1989. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Miyauchi, T. Kanekura, A. Yamaoka, M. Ozawa, S. Miyazawa, and T. Muramatsu, “Basigin, a new, broadly distributed member of the immunoglobulin superfamily, has strong homology with both the immunoglobulin V domain and the β-chain of major histocompatibility complex class II antigen,” Journal of Biochemistry, vol. 107, no. 2, pp. 316–323, 1990. View at Google Scholar · View at Scopus
  43. T. Kosugi, K. Maeda, W. Sato et al., “CD147 (EMMPRIN/Basigin) in kidney diseases: from an inflammation and immune system viewpoint,” Nephrology Dialysis Transplantation, 2014. View at Publisher · View at Google Scholar
  44. C. Biswas, “Tumor cell stimulation of collagenase production by fibroblasts,” Biochemical and Biophysical Research Communications, vol. 109, no. 3, pp. 1026–1034, 1982. View at Publisher · View at Google Scholar · View at Scopus
  45. X. Tang, N. Guo, L. Xu, X. Gou, and M. Mi, “CD147/EMMPRIN: an effective therapeutic target for hepatocellular carcinoma,” Journal of Drug Targeting, vol. 21, no. 3, pp. 224–231, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Chen, H. Zhang, X. Gou, Y. Horikawa, J. Xing, and Z. Chen, “Upregulation of HAb18G/CD147 in activated human umbilical vein endothelial cells enhances the angiogenesis,” Cancer Letters, vol. 278, no. 1, pp. 113–121, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. W. Kasinrerk, E. Fiebiger, I. Stefanová, T. Baumruker, W. Knapp, and H. Stockinger, “Human leukocyte activation antigen M6, a member of the Ig superfamily, is the species homologue of rat OX-47, mouse basigin, and chicken HT7 molecule,” The Journal of Immunology, vol. 149, no. 3, pp. 847–854, 1992. View at Google Scholar · View at Scopus
  48. C. Biswas, Y. Zhang, R. DeCastro et al., “The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily,” Cancer Research, vol. 55, no. 2, pp. 434–439, 1995. View at Google Scholar · View at Scopus
  49. H. Hoffmann and C. Schiene-Fischer, “Functional aspects of extracellular cyclophilins,” Biological Chemistry, vol. 395, no. 7-8, pp. 721–735, 2014. View at Publisher · View at Google Scholar
  50. N. J. Philp, J. D. Ochrietor, C. Rudoy, T. Muramatsu, and P. J. Linser, “Loss of MCT1, MCT3, and MCT4 expression in the retinal pigment epithelium and neural retina of the 5A11/basigin-null mouse,” Investigative Ophthalmology and Visual Science, vol. 44, no. 3, pp. 1305–1311, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. F. Berditchevski, S. Chang, J. Bodorova, and M. E. Hemler, “Generation of monoclonal antibodies to integrin-associated proteins. Evidence that α3β1 complexes with emmprin/basigin/OX47/M6,” The Journal of Biological Chemistry, vol. 272, no. 46, pp. 29174–29180, 1997. View at Publisher · View at Google Scholar · View at Scopus
  52. C.-H. Wang, J.-Y. Dai, L. Wang et al., “Expression of CD147 (EMMPRIN) on neutrophils in rheumatoid arthritis enhances chemotaxis, matrix metalloproteinase production and invasiveness of synoviocytes,” Journal of Cellular and Molecular Medicine, vol. 15, no. 4, pp. 850–860, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Y. Cho, D. A. Fox, V. Horejsi et al., “The functional interactions between CD98, β1-integrins, and CD147 in the induction of U937 homotypic aggregation,” Blood, vol. 98, no. 2, pp. 374–382, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. I. G. Winkler, V. Barbier, B. Nowlan et al., “Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance,” Nature Medicine, vol. 18, no. 11, pp. 1651–1657, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. X. Zhu, Z. Song, S. Zhang, A. Nanda, and G. Li, “CD147: a novel modulator of inflammatory and immune disorders,” Current Medicinal Chemistry, vol. 21, no. 19, pp. 2138–2145, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. S. M. Agrawal and V. W. Yong, “The many faces of EMMPRIN—roles in neuroinflammation,” Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, vol. 1812, no. 2, pp. 213–219, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. W. Tang and M. E. Hemler, “Caveolin-1 regulates matrix metalloproteinases-1 induction and CD147/EMMPRIN cell surface clustering,” The Journal of Biological Chemistry, vol. 279, no. 12, pp. 11112–11118, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. L. Jia, S. Wang, H. Zhou, J. Cao, Y. Hu, and J. Zhang, “Caveolin-1 up-regulates CD147 glycosylation and the invasive capability of murine hepatocarcinoma cell lines,” International Journal of Biochemistry and Cell Biology, vol. 38, no. 9, pp. 1584–1593, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. W. M. Gwinn, J. M. Damsker, R. Falahati et al., “Novel approach to inhibit asthma-mediated lung inflammation using Anti-CD147 intervention,” Journal of Immunology, vol. 177, no. 7, pp. 4870–4879, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. K. Arora, W. M. Gwinn, M. A. Bower et al., “Extracellular cyclophilins contribute to the regulation of inflammatory responses,” The Journal of Immunology, vol. 175, no. 1, pp. 517–522, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. C.-H. Wang, H. Yao, L.-N. Chen et al., “CD147 induces angiogenesis through a vascular endothelial growth factor and hypoxia-inducible transcription factor 1α-mediated pathway in rheumatoid arthritis,” Arthritis & Rheumatism, vol. 64, no. 6, pp. 1818–1827, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. T.-T. Zhang, J.-F. Zhang, and H. Ge, “Functions of cyclophilin A in atherosclerosis,” Experimental and Clinical Cardiology, vol. 18, no. 2, pp. e118–e124, 2013. View at Google Scholar · View at Scopus
  63. K. Satoh, Y. Fukumoto, K. Sugimura et al., “Plasma cyclophilin a is a novel biomarker for coronary artery disease,” Circulation Journal, vol. 77, no. 2, pp. 447–455, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Sato, Y. Nakai, W. Nakata et al., “EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome,” PLoS ONE, vol. 8, no. 9, Article ID e74313, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. L. Dai, L. Bai, Y. Lu et al., “Emmprin and KSHV: new partners in viral cancer pathogenesis,” Cancer Letters, vol. 337, no. 2, pp. 161–166, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. Tang, P. Kesavan, M. T. Nakada, and L. Yan, “Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN,” Molecular Cancer Research, vol. 2, no. 2, pp. 73–80, 2004. View at Google Scholar · View at Scopus
  67. K. Bahmed, C. Henry, M. Holliday et al., “Extracellular cyclophilin-A stimulates ERK1/2 phosphorylation in a cell-dependent manner but broadly stimulates nuclear factor kappa B,” Cancer Cell International, vol. 12, no. 1, article 19, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. R. Schmidt, A. Bültmann, S. Fischel et al., “Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor κB-dependent inflammation in monocytes,” Circulation Research, vol. 102, no. 3, pp. 302–309, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. P. Seizer, C. Ochmann, T. Schönberger et al., “Disrupting the EMMPRIN (CD147)-cyclophilin a interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 6, pp. 1377–1386, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. Li, J. Xu, L. Chen et al., “HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection,” Histopathology, vol. 54, no. 6, pp. 677–687, 2009. View at Google Scholar
  71. M. Yang, Y. Yuan, H. Zhang et al., “Prognostic significance of CD147 in patients with glioblastoma,” Journal of Neuro-Oncology, vol. 115, no. 1, pp. 19–26, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics, 2013,” CA: A Cancer Journal for Clinicians, vol. 63, no. 1, pp. 11–30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. W.-C. Tsai, Y.-C. Chao, W.-H. Lee, A. Chen, L.-F. Sheu, and J.-S. Jin, “Increasing EMMPRIN and matriptase expression in hepatocellular carcinoma: tissue microarray analysis of immunohistochemical scores with clinicopathological parameters,” Histopathology, vol. 49, no. 4, pp. 388–395, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. W. C. Tsai, L. F. Sheu, S. Nieh et al., “Association of EMMPRIN and fascin expression in renal cell carcinoma: correlation with clinicopathological parameters,” World Journal of Urology, vol. 25, no. 1, pp. 73–80, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. Y.-X. Liang, H.-C. He, Z.-D. Han et al., “CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value,” Cancer Investigation, vol. 27, no. 7, pp. 788–793, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. J. Lee and S. S. Kim, “An overview of cyclophilins in human cancers,” Journal of International Medical Research, vol. 38, no. 5, pp. 1561–1574, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Li, Q. Zhai, U. Bharadwaj et al., “Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147,” Cancer, vol. 106, no. 10, pp. 2284–2294, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. V. Yurchenko, T. Pushkarsky, J.-H. Li, W. W. Dai, B. Sherry, and M. Bukrinsky, “Regulation of CD147 cell surface expression: involvement of the proline residue in the CD147 transmembrane domain,” The Journal of Biological Chemistry, vol. 280, no. 17, pp. 17013–17019, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. R. Bellomo, J. A. Kellum, and C. Ronco, “Acute kidney injury,” The Lancet, vol. 380, no. 9843, pp. 756–766, 2012. View at Publisher · View at Google Scholar · View at Scopus
  80. A. Tolwani, “Continuous renal-replacement therapy for acute kidney injury,” The New England Journal of Medicine, vol. 367, no. 26, pp. 2505–2514, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. S. Uchino, J. A. Kellum, R. Bellomo et al., “Acute renal failure in critically ill patients: a multinational, multicenter study,” The Journal of the American Medical Association, vol. 294, no. 7, pp. 813–818, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. J. W. Dear, A. Leelahavanichkul, A. Aponte et al., “Liver proteomics for therapeutic drug discovery: inhibition of the cyclophilin receptor CD147 attenuates sepsis-induced acute renal failure,” Critical Care Medicine, vol. 35, no. 10, pp. 2319–2328, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. H. Gomez, C. Ince, D. de Backer et al., “A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury,” Shock, vol. 41, no. 1, pp. 3–11, 2014. View at Publisher · View at Google Scholar · View at Scopus
  84. V. Yurchenko, S. Constant, and M. Bukrinsky, “Dealing with the family: CD147 interactions with cyclophilins,” Immunology, vol. 117, no. 3, pp. 301–309, 2006. View at Publisher · View at Google Scholar · View at Scopus
  85. J. Y. Kim, W. J. Kim, H. Kim et al., “The stimulation of CD147 induces MMP-9 expression through ERK and NF-kappaB in macrophages: implication for atherosclerosis,” Immune Network, vol. 9, no. 3, pp. 90–97, 2009. View at Google Scholar
  86. S. Zhu, Y. Li, Y. Zhang et al., “Expression and clinical implications of HAb18G/CD147 in hepatocellular carcinoma,” Hepatology Research, 2014. View at Publisher · View at Google Scholar · View at Scopus
  87. M. Maeda-Hori, T. Kosugi, H. Kojima et al., “Plasma CD147 reflects histological features in patients with lupus nephritis,” Lupus, vol. 23, no. 4, pp. 342–352, 2014. View at Google Scholar
  88. J. Coresh, B. C. Astor, T. Greene, G. Eknoyan, and A. S. Levey, “Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey,” American Journal of Kidney Diseases, vol. 41, no. 1, pp. 1–12, 2003. View at Google Scholar · View at Scopus
  89. N. Lameire, K. Jager, W. van Biesen, D. de Bacquer, and R. Vanholder, “Chronic kidney disease: a European perspective,” Kidney international. Supplement., vol. 99, pp. S30–S38, 2005. View at Google Scholar · View at Scopus
  90. T. A. Wynn, “Fibrosis under arrest,” Nature Medicine, vol. 16, no. 5, pp. 523–525, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. L. Yang, T. Y. Besschetnova, C. R. Brooks, J. V. Shah, and J. V. Bonventre, “Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury,” Nature Medicine, vol. 16, no. 5, pp. 535–543, 2010. View at Publisher · View at Google Scholar · View at Scopus
  92. D. Tampe and M. Zeisberg, “Potential approaches to reverse or repair renal fibrosis,” Nature Reviews Nephrology, vol. 10, no. 4, pp. 226–237, 2014. View at Publisher · View at Google Scholar · View at Scopus
  93. B. Lange-Sperandio, F. Cachat, B. A. Thornhill, and R. L. Chevalier, “Selectins mediate macrophage infiltration in obstructive nephropathy in newborn mice,” Kidney International, vol. 61, no. 2, pp. 516–524, 2002. View at Publisher · View at Google Scholar · View at Scopus
  94. D.-W. Zhang, Y.-X. Zhao, D. Wei et al., “HAb18G/CD147 promotes activation of hepatic stellate cells and is a target for antibody therapy of liver fibrosis,” Journal of Hepatology, vol. 57, no. 6, pp. 1283–1291, 2012. View at Publisher · View at Google Scholar · View at Scopus
  95. N. Kato, T. Kosugi, W. Sato et al., “Basigin/CD147 promotes renal fibrosis after unilateral ureteral obstruction,” The American Journal of Pathology, vol. 178, no. 2, pp. 572–579, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. P. Seizer, K. Klingel, M. Sauter et al., “Cyclophilin A affects inflammation, virus elimination and myocardial fibrosis in coxsackievirus B3-induced myocarditis,” Journal of Molecular and Cellular Cardiology, vol. 53, no. 1, pp. 6–14, 2012. View at Publisher · View at Google Scholar · View at Scopus
  97. H. Wang, Y. Zhang, T. Wang, H. You, and J. Jia, “N-methyl-4-isoleucine cyclosporine attenuates CCl4-induced liver fibrosis in rats by interacting with cyclophilin B and D,” Journal of Gastroenterology and Hepatology, vol. 26, no. 3, pp. 558–567, 2011. View at Publisher · View at Google Scholar · View at Scopus